1 – 100 of 149
- show: 100
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2024
-
Mark
Diagnostic Accuracy of the Swedish Version of the Multicultural Cognitive Examination for Cognitive Assessment in Swedish Memory Clinics
(
- Contribution to journal › Article
-
Mark
The Paintings Reveal the Story : Case Study of a Well-Known Swedish Artist Suffering from Alzheimer's Disease
(
- Contribution to journal › Article
- 2023
-
Mark
Exploring the prevalence of undetected bradyarrhythmia in dementia with Lewy bodies
2023) In Clinical autonomic research : official journal of the Clinical Autonomic Research Society 33(4). p.433-442(
- Contribution to journal › Article
-
Mark
Pacemaker Implants and Their Influence on the Daily Life of Patients with Dementia with Lewy Bodies : A Qualitative Case Study
(
- Contribution to journal › Article
-
Mark
Development of the Swedish anticholinergic burden scale (Swe-ABS)
(
- Contribution to journal › Article
- 2022
-
Mark
Inter-modality assessment of medial temporal lobe atrophy in a non-demented population : application of a visual rating scale template across radiologists with varying clinical experience
(
- Contribution to journal › Article
-
Mark
Choral Singing Enriches Everyday Life for People With Mild to Moderate Dementia and Their Family Caregivers
(
- Contribution to journal › Article
-
Mark
Diagnostic Accuracy of the Swedish Version of the Rowland Universal Dementia Assessment Scale (RUDAS-S) for Multicultural Cognitive Screening in Swedish Memory Clinics
(
- Contribution to journal › Article
-
Mark
A Retrospective Study on Clinical Assessment of Cognitive Impairment in a Swedish Cohort : Is There Inequality Between Natives and Foreign-Born?
(
- Contribution to journal › Article
-
Mark
“I Know Hyena. Do you Know Hyena?” Challenges in Interpreter-Mediated Dementia Assessment, Focusing on the Role of the Interpreter
(
- Contribution to journal › Article
- 2021
-
Mark
Predictors of mortality in patients with different apolipoprotein E genotypes—a 20-year follow-up of Alzheimer’s disease.
2021) 15th International Conference on Alzheimer's and Parkinson's Diseases (AD/PD 2021)(
- Contribution to conference › Abstract
-
Mark
Medications causing potential cognitive impairment are common in nursing home dementia units – A cross-sectional study
(
- Contribution to journal › Article
-
Mark
Genome sequencing analysis identifies new loci associated with Lewy body dementia and provides insights into its genetic architecture
(
- Contribution to journal › Article
-
Mark
Plasma Phospho-Tau Identifies Alzheimer's Co-Pathology in Patients with Lewy Body Disease
(
- Contribution to journal › Article
- 2020
-
Mark
Analysis of neurodegenerative disease-causing genes in dementia with Lewy bodies
(
- Contribution to journal › Article
-
Mark
Reporting frequency of radiology findings increases after introducing visual rating scales in the primary care diagnostic work up of subjective and mild cognitive impairment
2020) In European Radiology(
- Contribution to journal › Article
-
Mark
The interaction effect of sex and apolipoprotein E genotype in Alzheimer’s disease—rates of progression and prognosis.
2020) Advances in Alzheimer's and Parkinson's Therapies (AAT-AD/PD) Focus Meeting 2020(
- Contribution to conference › Abstract
-
Mark
β-Amyloid and tau biomarkers and clinical phenotype in dementia with Lewy bodies
(
- Contribution to journal › Debate/Note/Editorial
- 2019
-
Mark
Extreme sleep pattern in Lewy body dementia : A hypothalamic matter?
(
- Contribution to journal › Article
-
Mark
Structural imaging findings on non-enhanced computed tomography are severely underreported in the primary care diagnostic work-up of subjective cognitive decline
(
- Contribution to journal › Article
-
Mark
Living with dementia with Lewy bodies: an interpretative phenomenological analysis
(
- Contribution to journal › Article
-
Mark
A comprehensive screening of copy number variability in dementia with Lewy bodies
(
- Contribution to journal › Article
-
Mark
Prognostic regression models of life expectancy after diagnosis of Alzheimer’s disease – a 20-year follow-up.
2019) Alzheimer's Association International Conference (AAIC), 2019(
- Contribution to conference › Poster
-
Mark
Inför specialistutbildning i kognitiv medicin för läkare
(
- Contribution to journal › Debate/Note/Editorial
-
Mark
Sex differences in predictors of mortality in patients with Alzheimer’s disease – A 20-year follow-up.
2019) 14th International Conference on Alzheimer's and Parkinson's Diseases (AD/PD 2019)(
- Contribution to conference › Abstract
-
Mark
Heritability and genetic variance of dementia with Lewy bodies
(
- Contribution to journal › Article
-
Mark
Survival among the older adults with clinical signs of Lewy body dementia in 40 Swedish nursing homes : A 6-year follow-up study
(
- Contribution to journal › Article
-
Mark
GBA and APOE ε4 associate with sporadic dementia with Lewy bodies in European genome wide association study
(
- Contribution to journal › Article
-
Mark
Sex differences in predictors of cognitive and functional outcomes in patients with Alzheimer’s disease.
2019) 12th Clinical Trials on Alzheimer’s Disease Conference(
- Contribution to conference › Poster
- 2018
-
Mark
Psychotropic and anti-dementia treatment in elderly persons with clinical signs of dementia with Lewy bodies : A cross-sectional study in 40 nursing homes in Sweden
(
- Contribution to journal › Article
-
Mark
Investigating the genetic architecture of dementia with Lewy bodies : a two-stage genome-wide association study
(
- Contribution to journal › Article
-
Mark
18F-AV-1451 in Parkinson's Disease with and without dementia and in Dementia with Lewy Bodies
(
- Contribution to journal › Article
-
Mark
Predictors of mortality in early- versus late-onset Alzheimer’s disease – an 18-year follow-up.
2018) Alzheimer’s Association International Conference (AAIC), 2018(
- Contribution to conference › Poster
-
Mark
Relative survival in patients with dementia with Lewy bodies and Parkinson’s disease dementia
(
- Contribution to journal › Article
-
Mark
Short-term response to cholinesterase inhibitors in Alzheimer’s disease delays time to nursing home placement
(
- Contribution to journal › Article
- 2017
-
Mark
Analysis of C9orf72 repeat expansions in a large international cohort of dementia with Lewy bodies
(
- Contribution to journal › Article
-
Mark
Response to the Letter From Abid Iraqi, MD, CMD and Terry Hughes, RN, CS
(
- Contribution to journal › Letter
-
Mark
Effects of carbonated liquid on swallowing dysfunction in dementia with Lewy bodies and Parkinson’s disease dementia
(
- Contribution to journal › Article
-
Mark
Long-Term Cognitive Decline in Dementia with Lewy Bodies in a Large Multicenter, International Cohort
(
- Contribution to journal › Article
-
Mark
The course and end-points of Alzheimer’s disease according to sociodemographics, apolipoprotein E genotype and cognitive ability.
2017) Alzheimer's Association International Conference (AAIC), 2017(
- Contribution to conference › Poster
-
Mark
Dementia with Lewy Body (DLB) Symptoms Hidden within the Diagnosis “Dementia Not Otherwise Specified” a Cross-Sectional Study in 40 Swedish Nursing Homes.
2017) Alzheimer's Association International Conference (AAIC), 2017(
- Contribution to conference › Poster
-
Mark
Importance and added value of functional impairment to predict mortality : A cohort study in Swedish medical inpatients
(
- Contribution to journal › Article
-
Mark
The outcomes of different assessment scales can predict survival in patients with Alzheimer’s disease
2017) 13th International Conference on Alzheimer's and Parkinson's Diseases (AD/PD 2017) In Neurodegenerative Diseases 17(Suppl. 1). p.27-27(
- Contribution to journal › Published meeting abstract
- 2016
-
Mark
Genome-wide analysis of genetic correlation in dementia with Lewy bodies, Parkinson's and Alzheimer's diseases.
(
- Contribution to journal › Article
-
Mark
Short-term response to cholinesterase inhibitors in Alzheimer’s disease delays time to nursing home placement.
2016) 14th International Athens/Springfield Symposium on Advances in Alzheimer Therapy In Neurobiology of Aging 39(Suppl. 1). p.2-2(
- Contribution to journal › Published meeting abstract
-
Mark
Associations between TOMM40 Poly-T Repeat Variants and Dementia in Cases with Parkinsonism.
(
- Contribution to journal › Article
-
Mark
Alzheimer's disease cerebrospinal fluid biomarkers predict cognitive decline in lewy body dementia
(
- Contribution to journal › Article
-
Mark
Cholinesterase inhibitors do not alter the length of stay in nursing homes among patients with Alzheimer's disease : A prospective, observational study of factors affecting survival time from admission to death.
(
- Contribution to journal › Article
-
Mark
Cerebrospinal fluid Alzheimer's disease biomarkers across the spectrum of lewy body diseases : Results from a large multicenter cohort
(
- Contribution to journal › Article
-
Mark
Cholinesterase inhibitor therapy does not affect time spent in nursing homes in patients with Alzheimer’s disease.
2016) Alzheimer’s Association International Conference 2016(
- Contribution to conference › Poster
-
Mark
Prevalence of Dementia With Lewy Body Symptoms : A Cross-Sectional Study in 40 Swedish Nursing Homes
(
- Contribution to journal › Article
-
Mark
Reliability, validity and clinical correlates of the Quality of Life in Alzheimer's disease (QoL-AD) scale in medical inpatients
(
- Contribution to journal › Article
- 2015
-
Mark
Cerebrospinal fluid levels of IL-6 are decreased and correlate with cognitive status in DLB patients.
(
- Contribution to journal › Article
-
Mark
Medial temporal lobe atrophy is underreported and may have important clinical correlates in medical inpatients.
(
- Contribution to journal › Article
-
Mark
Lack of orthostatic symptoms in dementia patients with orthostatic hypotension.
(
- Contribution to journal › Article
-
Mark
Longitudinal Associations between Survival in Alzheimer's Disease and Cholinesterase Inhibitor Use, Progression, and Community-Based Services.
(
- Contribution to journal › Article
-
Mark
Memantine improves attention and episodic memory in Parkinson's disease dementia and dementia with Lewy bodies
(
- Contribution to journal › Article
-
Mark
Increased CSF biomarkers of angiogenesis in Parkinson disease.
(
- Contribution to journal › Article
-
Mark
Various measures of progression predicting mortality in Alzheimer’s disease.
2015) Alzheimer’s Association International Conference (AAIC), 2015 In Alzheimer's & Dementia 11(7 Suppl.). p.293-294(
- Contribution to journal › Published meeting abstract
-
Mark
A Diagnostic Model for Dementia in Clinical Practice-Case Methodology Assisting Dementia Diagnosis.
(
- Contribution to journal › Article
-
Mark
Various outcomes of cholinesterase inhibitor treatment influence survival of patients with Alzheimer’s disease.
2015) 12th International Conference on Alzheimer`s and Parkinson`s Diseases (AD/PD 2015)(
- Contribution to conference › Poster
- 2014
-
Mark
Treatment effect of memantine on survival in dementia with Lewy bodies and Parkinson's disease with dementia: a prospective study.
(
- Contribution to journal › Article
-
Mark
Response to cholinesterase inhibitors affects lifespan in Alzheimer's disease.
(
- Contribution to journal › Article
-
Mark
Levels of cerebrospinal fluid α-synuclein oligomers are increased in Parkinson's disease with dementia and dementia with Lewy bodies compared to Alzheimer's disease.
(
- Contribution to journal › Article
-
Mark
Kynurenic Acid levels in cerebrospinal fluid from patients with Alzheimer's disease or dementia with lewy bodies.
(
- Contribution to journal › Article
-
Mark
Solitary living in Alzheimer's disease over 3 years: association between cognitive and functional impairment and community-based services.
(
- Contribution to journal › Article
-
Mark
Genetic analysis implicates APOE, SNCA and suggests lysosomal dysfunction in the etiology of Dementia with Lewy Bodies.
(
- Contribution to journal › Article
-
Mark
Determining the Association of the 5HTTLPR Polymorphism with Delusions and Hallucinations in Lewy Body Dementias
(
- Contribution to journal › Article
-
Mark
Risk Factors That Affect Life Expectancy in Alzheimer's Disease: A 15-Year Follow-Up.
(
- Contribution to journal › Article
-
Mark
Low Levels of Soluble NG2 in Cerebrospinal Fluid from Patients with Dementia with Lewy Bodies.
2014) In Journal of Alzheimer's Disease(
- Contribution to journal › Article
-
Mark
Factors that affect life-span in mild versus moderate Alzheimer’s disease.
2014) 13th International Geneva/Springfield Symposium on Advances in Alzheimer Therapy In Neurobiology of Aging 35(Suppl. 1). p.25-25(
- Contribution to journal › Published meeting abstract
-
Mark
Prevalence of Lewy body dementia and neuroleptic treatment in nursing homes in Malmö, Sweden.
2014) Alzheimer’s Association International Conference (AAIC), 2014(
- Contribution to conference › Poster
-
Mark
The effect of functional capacity and concomitant medications on life expectancy in Alzheimer’s disease.
2014) Alzheimer’s Association International Conference (AAIC), 2014(
- Contribution to conference › Poster
- 2013
-
Mark
Dysphagia in Lewy body dementia - a clinical observational study of swallowing function by videofluoroscopic examination
(
- Contribution to journal › Article
-
Mark
Evaluation of Systolic and Diastolic Hypotension in Dementia with Lewy Bodies and Alzheimer’s Disease.
(
- Contribution to journal › Article
-
Mark
Correlations of CSF tau and amyloid levels with Alzheimer pathology in neuropathologically verified dementia with Lewy bodies.
(
- Contribution to journal › Article
-
Mark
A longitudinal study of risk factors for community-based home help services in Alzheimer's disease: the influence of cholinesterase inhibitor therapy
(
- Contribution to journal › Article
-
Mark
Evaluation of the Cerebrospinal Fluid Amyloid-beta(1-42)/Amyloid-beta(1-40) Ratio Measured by Alpha-LISA to Distinguish Alzheimer's Disease from Other Dementia Disorders
(
- Contribution to journal › Article
-
Mark
Multidisciplinary intervention reducing readmissions in medical inpatients: a prospective, non-randomized study
(
- Contribution to journal › Article
- 2012
-
Mark
A longitudinal study of physical function in patients with early-onset dementia
(
- Contribution to journal › Article
-
Mark
Comparison of Brief Cognitive Tests and CSF Biomarkers in Predicting Alzheimer's Disease in Mild Cognitive Impairment: Six-Year Follow-Up Study.
(
- Contribution to journal › Article
-
Mark
The impact of autonomic dysfunction on survival in patients with dementia with lewy bodies and Parkinson's disease with dementia.
(
- Contribution to journal › Article
-
Mark
Cognitive impairment is undetected in medical inpatients: a study of mortality and recognition amongst healthcare professionals
(
- Contribution to journal › Article
-
Mark
Gender-dependent levels of hyaluronic acid in cerebrospinal fluid of patients with neurodegenerative dementia.
(
- Contribution to journal › Article
-
Mark
A Pilot Study Examining Associations between DYRK1A and alpha-Synuclein Dementias
(
- Contribution to journal › Article
-
Mark
No association of COMT val158met polymorphism and psychotic symptoms in Lewy body dementias
(
- Contribution to journal › Article
-
Mark
Accuracy of a Panel of 5 Cerebrospinal Fluid Biomarkers in the Differential Diagnosis of Patients With Dementia and/or Parkinsonian Disorders
(
- Contribution to journal › Article
-
Mark
CSF Biomarkers Correlate with Cerebral Blood Flow on SPECT in Healthy Elderly.
(
- Contribution to journal › Article
-
Mark
Altered CSF Orexin and α-Synuclein Levels in Dementia Patients.
(
- Contribution to journal › Article
-
Mark
A new automated method for analysis of rCBF-SPECT images based on the active-shape algorithm: normal values.
(
- Contribution to journal › Article
-
Mark
Risk factors for community-based home help services among patients with Alzheimer’s disease.
2012) 21st Nordic Congress of Gerontology(
- Contribution to conference › Poster
- 2011
-
Mark
Long-term Outcome and Prediction Models of Activities of Daily Living in Alzheimer Disease With Cholinesterase Inhibitor Treatment.
(
- Contribution to journal › Article
-
Mark
CSF amyloid beta 38 as a novel diagnostic marker for dementia with Lewy bodies
(
- Contribution to journal › Article
-
Mark
Cerebrospinal fluid/plasma quotients of essential and non-essential metals in patients with Alzheimer's disease
(
- Contribution to journal › Article
-
Mark
Quality of Life and the Effect of Memantine in Dementia with Lewy Bodies and Parkinson's Disease Dementia.
(
- Contribution to journal › Article
-
Mark
Risk Factors for Nursing Home Placement in Alzheimer's Disease: A Longitudinal Study of Cognition, ADL, Service Utilization, and Cholinesterase Inhibitor Treatment.
(
- Contribution to journal › Article
-
Mark
Predictors of long-term cognitive outcome in Alzheimer's disease.
(
- Contribution to journal › Article
-
Mark
Differences in Survival between Patients with Dementia with Lewy Bodies and Patients with Alzheimer's Disease - Measured from a Fixed Cognitive Level.
(
- Contribution to journal › Article
-
Mark
The cognitive profile and CSF biomarkers in dementia with Lewy bodies and Parkinson's disease dementia.
(
- Contribution to journal › Article
-
Mark
Efficacy of memantine in PDD and DLB: an extension study including washout and open-label treatment.
(
- Contribution to journal › Article